| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ziva D Cooper, Donald I Abrams, Steven Gust, Alejandro Salicrup, Douglas C Throckmorto. Challenges for Clinical Cannabis and Cannabinoid Research in the United States. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850896. |
three primary barriers contribute to the difficulty in initiating research geared toward answering the most pressing public health questions: the us regulatory status of cannabis and cannabinoids, sources for cannabis and cannabinoid study medications, and limited funding and resources to support studies. |
2021-12-01 |
2023-08-13 |
Not clear |
| Ziva D Cooper, Donald I Abrams, Steven Gust, Alejandro Salicrup, Douglas C Throckmorto. Challenges for Clinical Cannabis and Cannabinoid Research in the United States. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850896. |
here, challenges and barriers to cannabis and cannabinoid research are described from the perspectives of the national institute on drug abuse, national institutes of health; the us food and drug administration; and 2 clinical researchers. |
2021-12-01 |
2023-08-13 |
Not clear |
| Ziva D Cooper, Donald I Abrams, Steven Gust, Alejandro Salicrup, Douglas C Throckmorto. Challenges for Clinical Cannabis and Cannabinoid Research in the United States. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850896. |
barriers specifically to studying cannabis, cannabinoids, and cancer are emphasized. |
2021-12-01 |
2023-08-13 |
Not clear |
| Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark, Mark S Wallac. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850897. |
the management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids. |
2021-12-01 |
2023-08-13 |
Not clear |
| Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark, Mark S Wallac. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850897. |
cannabis and cannabinoids are increasingly being accessed and used by patients with advanced cancer for various symptoms and general quality of life. |
2021-12-01 |
2023-08-13 |
Not clear |
| Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark, Mark S Wallac. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850897. |
this conference report from the national cancer institute's "cannabis, cannabinoid and cancer research symposium" on the topic of "cancer symptom/treatment side effect management" is an expert perspective of cannabis intervention for cancer and cancer treatment-related symptoms. |
2021-12-01 |
2023-08-13 |
Not clear |
| Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark, Mark S Wallac. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850897. |
together, these steps will further aid in refining the use of cannabis and cannabinoids for symptom palliation and improve safety and efficacy for patients. |
2021-12-01 |
2023-08-13 |
Not clear |
| Ilana M Braun, Donald I Abrams, Stacey E Blansky, Steven A Perga. Cannabis and the Cancer Patient. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850899. |
session 2 of the national cancer institute's cannabis, cannabinoids, and cancer research workshop opened with testimony from a lymphoma survivor who detailed medicinal cannabis-related improvements in nausea, low appetite, insomnia, and mental health and the limited clinical counsel she received regarding cannabis use. |
2021-12-01 |
2023-08-13 |
Not clear |
| Sean D McAllister, Mary E Abood, Joseph Califano, Manuel Guzmá. Cannabinoid Cancer Biology and Prevention. Journal of the National Cancer Institute. Monographs. vol 2021. issue 58. 2021-12-01. PMID:34850900. |
session 5 of the national cancer institute's cannabis, cannabinoids and cancer research symposium provides an overview of this research topic. |
2021-12-01 |
2023-08-13 |
human |
| Abhilash Perisetti, Hemant Goya. Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update. European journal of gastroenterology & hepatology. vol 34. issue 1. 2021-11-30. PMID:33208685. |
endocannabinoid system and cannabis hyperemesis syndrome: a narrative update. |
2021-11-30 |
2023-08-13 |
Not clear |
| Abhilash Perisetti, Hemant Goya. Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update. European journal of gastroenterology & hepatology. vol 34. issue 1. 2021-11-30. PMID:33208685. |
the cannabis plant has more than 400 chemicals, of which more than 100 cannabinoids (such as cannabigerol, cannabidiol, and cannabinol) have been identified. |
2021-11-30 |
2023-08-13 |
Not clear |
| Abhilash Perisetti, Hemant Goya. Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update. European journal of gastroenterology & hepatology. vol 34. issue 1. 2021-11-30. PMID:33208685. |
the endocannabinoid system (ecs) plays an essential role in the effects of cannabis on end organs. |
2021-11-30 |
2023-08-13 |
Not clear |
| Babette Van Rafelghem, Adrian Covaci, Kurt Anseeuw, Alexander L N van Nuijs, Hugo Neels, Boris Mahieu, Werner Jacob. Suicide by vaping the synthetic cannabinoid 4F-MDMB-BINACA: cannabinoid receptors and fluoride at the crossroads of toxicity? Forensic science, medicine, and pathology. vol 17. issue 4. 2021-11-30. PMID:34542803. |
as cannabis use has been etiologically linked to acute pancreatitis, we hypothesize that the more afferent and potent 4f-mdmb-binaca could induce acute pancreatitis via stimulation of cannabinoid (cb)1-receptors. |
2021-11-30 |
2023-08-13 |
Not clear |
| William C Goedel, Alexandria Macmadu, Abdullah Shihipar, Patience Moyo, Magdalena Cerdá, Brandon D L Marshal. Association of medical cannabis licensure with prescription opioid receipt: A population-based, individual-level retrospective cohort study. The International journal on drug policy. vol 100. 2021-11-30. PMID:34695720. |
the endocannabinoid system has been implicated in physiological processes fundamental to pain, giving plausibility to the hypothesis that cannabis may be used as a substitute or complement to prescription opioids in the management of chronic pain. |
2021-11-30 |
2023-08-13 |
Not clear |
| Ana Carolina C de Sousa, Jill M Combrinck, Keletso Maepa, Timothy J Ega. THC shows activity against cultured Plasmodium falciparum. Bioorganic & medicinal chemistry letters. vol 54. 2021-11-30. PMID:34763083. |
the active ingredient of dronabinol is synthetic tetrahydrocannabinol (thc), which is one of the major cannabinoids from cannabis sativa. |
2021-11-30 |
2023-08-13 |
Not clear |
| Marta Baranowska-Kuczko, Hanna Kozłowska, Monika Kloza, Magdalena Kusaczuk, Ewa Harasim-Symbor, Michał Biernacki, Irena Kasacka, Barbara Malinowsk. Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension. Pharmaceuticals (Basel, Switzerland). vol 14. issue 11. 2021-11-30. PMID:34832902. |
vasoprotective endothelial effects of chronic cannabidiol treatment and its influence on the endocannabinoid system in rats with primary and secondary hypertension. |
2021-11-30 |
2023-08-13 |
rat |
| Éamon Jones, Styliani Vlacho. Cannabidiol Does Not Cause Significant Changes to Working Memory Performance in the N-Back Task. Pharmaceuticals (Basel, Switzerland). vol 14. issue 11. 2021-11-30. PMID:34832947. |
more recently, over 100 different cannabinoid compounds have been identified, one of which is cannabidiol (cbd), a compound widely used for anti-inflammatory and anxiolytic treatment. |
2021-11-30 |
2023-08-13 |
human |
| Hussein Hamad, Birgitte Brinkmann Olse. Cannabidiol Induces Cell Death in Human Lung Cancer Cells and Cancer Stem Cells. Pharmaceuticals (Basel, Switzerland). vol 14. issue 11. 2021-11-30. PMID:34832951. |
cannabidiol (cbd) is a cannabinoid with anti-tumor properties. |
2021-11-30 |
2023-08-13 |
human |
| Meie Chao, Heidi Öblom, Claus Cornett, Johan Bøtker, Jukka Rantanen, Sofia Kälvemark Sporrong, Natalja Genin. Data-Enriched Edible Pharmaceuticals (DEEP) with Bespoke Design, Dose and Drug Release. Pharmaceutics. vol 13. issue 11. 2021-11-30. PMID:34834281. |
cannabinoids, namely, cannabidiol (cbd) and delta-9-tetrahydrocannabinol (thc), were used as the model active pharmaceutical ingredients (apis). |
2021-11-30 |
2023-08-13 |
Not clear |
| Rachel Riera, Rafael Leite Pacheco, Ângela Maria Bagattini, Ana Luiza Cabrera Martimbianc. Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: Overview of systematic reviews. Phytotherapy research : PTR. 2021-11-29. PMID:34841610. |
evidence certainty was moderate for the following: (a) cannabidiol appears to be beneficial for quality of life but increases the risk of adverse events in ulcerative colitis; (b) cannabinoids in general appear to have no clinically important benefit for chronic non-oncologic pain, spasticity-related pain in multiple sclerosis, or for acute post-operative pain; (c) cannabinoids in general appear to have a benefit in reducing chemotherapy-related nausea and vomiting. |
2021-11-29 |
2023-08-13 |
Not clear |